Daily Bulletin

Men's Weekly

.

Mallinckrodt and Terumo Blood and Cell Technologies Announce Positive Recommendations in Australia for Public Funding of UVADEX® (methoxsalen) for ECP Administration with the THERAKOS® CELLEX® Photopheresis System for Chronic Graft Versus Host Disease

  • Written by PR Newswire Asia - Daily Bulletin Au RSS

– In a dual-review process, two independent advisory committees to the Australian Minister for Health recommended reimbursement based on a favorable clinical and cost-effectiveness comparison –

DUBLIN and LAKEWOOD, Colo., Oct. 28, 2021 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKKQ), a global biopharmaceutical company, and...

Read more: Mallinckrodt and Terumo Blood and Cell Technologies Announce Positive Recommendations in Australia...

Business News

Workplace Health Checks: A Smart Investment for Small Business Success

Running a small business means every team member counts and when poor health leads to absenteeism or low energy, productivity and profits take a hit. Lost workdays, rising healthcare costs, and staff ...

Daily Bulletin - avatar Daily Bulletin

Rising Demand: Why Melbourne Needs More Electricians Now

Melbourne is running on change. Rooftops are filling with solar, carports are getting charge points, and older switchboards are being rebuilt so homes and shops can carry smarter, heavier loads. If yo...

Daily Bulletin - avatar Daily Bulletin

What Designers Really Think About Your Current Marketing Collateral

Key Takeaways: Designers notice structure, typography, and colour choices before the content itself Consistency across all collateral strengthens brand recognition and builds trust Overly bu...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals